| Dr Gabriel Kevin Kasovich, OD | |
|
4324 Veterans Memorial Blvd, Suite 104, Metairie, LA 70006-5445 | |
| (504) 455-9825 | |
| (504) 883-7669 |
| Full Name | Dr Gabriel Kevin Kasovich |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 20 Years |
| Location | 4324 Veterans Memorial Blvd, Metairie, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407959406 | NPI | - | NPPES |
| 1720712 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1394-524T (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eyecare Providers, Llc | 2567359318 | 12 |
News Archive
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that diluted earnings per share equaled $0.07 in the fourth quarter of fiscal 2010.
A three-pronged immunotherapy approach nearly doubles five-year survival among patients with rare leukemic form of cutaneous T-cell lymphoma, reports a new study by dermatologists from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania.
Bowel Cancer UK is announcing on World Cancer Day (Thursday 4 February) a new research project which will bring together 100 clinicians and scientists to identify gaps in current research into bowel cancer which, if addressed, will help save the lives of thousands of people diagnosed with the disease.
Plextronics, Inc. announced today that it has completed a $14 million Series B-1 financing round. The round was led by Solvay North American Investments, LLC, a member of the Solvay Group, which is an international chemical and pharmaceutical group headquartered in Brussels, Belgium. Marking Solvay's second investment in three years, this $12 million investment makes Solvay the largest minority shareholder in Plextronics.
› Verified 7 days ago
| Provider Name | Eyecare Providers, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1477628154 PECOS PAC ID: 2567359318 Enrollment ID: O20040304000481 |
News Archive
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that diluted earnings per share equaled $0.07 in the fourth quarter of fiscal 2010.
A three-pronged immunotherapy approach nearly doubles five-year survival among patients with rare leukemic form of cutaneous T-cell lymphoma, reports a new study by dermatologists from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania.
Bowel Cancer UK is announcing on World Cancer Day (Thursday 4 February) a new research project which will bring together 100 clinicians and scientists to identify gaps in current research into bowel cancer which, if addressed, will help save the lives of thousands of people diagnosed with the disease.
Plextronics, Inc. announced today that it has completed a $14 million Series B-1 financing round. The round was led by Solvay North American Investments, LLC, a member of the Solvay Group, which is an international chemical and pharmaceutical group headquartered in Brussels, Belgium. Marking Solvay's second investment in three years, this $12 million investment makes Solvay the largest minority shareholder in Plextronics.
› Verified 7 days ago
| Provider Name | Camile L. Chiasson, O.d., Apoc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1427144658 PECOS PAC ID: 0446282982 Enrollment ID: O20050907000004 |
News Archive
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that diluted earnings per share equaled $0.07 in the fourth quarter of fiscal 2010.
A three-pronged immunotherapy approach nearly doubles five-year survival among patients with rare leukemic form of cutaneous T-cell lymphoma, reports a new study by dermatologists from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania.
Bowel Cancer UK is announcing on World Cancer Day (Thursday 4 February) a new research project which will bring together 100 clinicians and scientists to identify gaps in current research into bowel cancer which, if addressed, will help save the lives of thousands of people diagnosed with the disease.
Plextronics, Inc. announced today that it has completed a $14 million Series B-1 financing round. The round was led by Solvay North American Investments, LLC, a member of the Solvay Group, which is an international chemical and pharmaceutical group headquartered in Brussels, Belgium. Marking Solvay's second investment in three years, this $12 million investment makes Solvay the largest minority shareholder in Plextronics.
› Verified 7 days ago
| Provider Name | Eyecare Providers, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1356505861 PECOS PAC ID: 2567359318 Enrollment ID: O20070502000181 |
News Archive
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that diluted earnings per share equaled $0.07 in the fourth quarter of fiscal 2010.
A three-pronged immunotherapy approach nearly doubles five-year survival among patients with rare leukemic form of cutaneous T-cell lymphoma, reports a new study by dermatologists from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania.
Bowel Cancer UK is announcing on World Cancer Day (Thursday 4 February) a new research project which will bring together 100 clinicians and scientists to identify gaps in current research into bowel cancer which, if addressed, will help save the lives of thousands of people diagnosed with the disease.
Plextronics, Inc. announced today that it has completed a $14 million Series B-1 financing round. The round was led by Solvay North American Investments, LLC, a member of the Solvay Group, which is an international chemical and pharmaceutical group headquartered in Brussels, Belgium. Marking Solvay's second investment in three years, this $12 million investment makes Solvay the largest minority shareholder in Plextronics.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gabriel Kevin Kasovich, OD 4324 Veterans Memorial Blvd, Suite 104, Metairie, LA 70006-5445 Ph: (504) 455-9825 | Dr Gabriel Kevin Kasovich, OD 4324 Veterans Memorial Blvd, Suite 104, Metairie, LA 70006-5445 Ph: (504) 455-9825 |
News Archive
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that diluted earnings per share equaled $0.07 in the fourth quarter of fiscal 2010.
A three-pronged immunotherapy approach nearly doubles five-year survival among patients with rare leukemic form of cutaneous T-cell lymphoma, reports a new study by dermatologists from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania.
Bowel Cancer UK is announcing on World Cancer Day (Thursday 4 February) a new research project which will bring together 100 clinicians and scientists to identify gaps in current research into bowel cancer which, if addressed, will help save the lives of thousands of people diagnosed with the disease.
Plextronics, Inc. announced today that it has completed a $14 million Series B-1 financing round. The round was led by Solvay North American Investments, LLC, a member of the Solvay Group, which is an international chemical and pharmaceutical group headquartered in Brussels, Belgium. Marking Solvay's second investment in three years, this $12 million investment makes Solvay the largest minority shareholder in Plextronics.
› Verified 7 days ago
Geesala Garvin, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3200 Severn Ave, Ste 102, Metairie, LA 70002 Phone: 504-887-2020 Fax: 504-887-7698 | |
Dr. Thomas Terrell Mcginn Jr., O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4324 Veterans Memorial Blvd, Suite 104, Metairie, LA 70006 Phone: 504-455-9825 Fax: 504-883-7669 | |
Mary Elizabeth Hood, OPTOMETRIST Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1431 Veterans Memorial Blvd, Metairie, LA 70005 Phone: 504-837-8323 Fax: 504-837-7344 | |
Langhetee Eye Center Llc Optometrist Medicare: Medicare Enrolled Practice Location: 2201 Veterans Memorial Blvd Ste 402, Metairie, LA 70002 Phone: 504-777-7733 Fax: 504-648-1418 | |
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3200 Severn Ave, Metairie, LA 70002 Phone: 504-541-9025 | |
Dr. James P Murphy, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3409 N Hullen St, Metairie, LA 70002 Phone: 504-888-2600 Fax: 504-456-9596 | |
Xuan T. Pham, O.d., Llc Optometrist Medicare: Medicare Enrolled Practice Location: 3900 Airline Dr, Metairie, LA 70001 Phone: 504-831-3662 Fax: 504-831-8272 |